PRQR - ProQR Therapeutics BV - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRQR is currently covered by 6 analysts with an average price target of $7.88. This is a potential upside of $5.87 (292.04%) from yesterday's end of day stock price of $2.01.

ProQR Therapeutics BV's activity chart (see below) currently has 12 price targets and 32 ratings on display. The stock rating distribution of PRQR is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.77% with an average time for these price targets to be met of 128.56 days.

Highest price target for PRQR is $6, Lowest price target is $2, average price target is $7.88.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Apr-2024. First documented stock forecast 26-Sep-2017.

Currently out of the existing stock ratings of PRQR, 16 are a BUY (80%), 4 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$0.01 (0.50%)

1.8

15 days ago

4/5 (80%)

$0.14 (7.53%)

23

Buy

2

$0.01 (0.50%)

2

5 months 25 days ago

4/4 (100%)

$0.65 (48.15%)

159

Buy

4

$2.01 (101.01%)

5

5 months 25 days ago

1/4 (25%)

$2.65 (196.30%)

132

Buy

5

$3.01 (151.26%)

5

8 months 26 days ago

2/7 (28.57%)

$3.58 (252.11%)

174

Buy

4.5

$2.51 (126.13%)

5

11 months 16 days ago

0/2 (0%)

$2.75 (157.14%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRQR (ProQR Therapeutics BV) average time for price targets to be met?

On average it took 128.56 days on average for the stock forecasts to be realized with a an average price target met ratio 40.77

Which analyst has the current highest performing score on PRQR (ProQR Therapeutics BV) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on PRQR (ProQR Therapeutics BV) with a proven track record?

DAE GON HA

Which analyst has the most public recommendations on PRQR (ProQR Therapeutics BV)?

Keay Nakae works at CHARDAN CAPITAL and has 19 price targets and 11 ratings on PRQR

Which analyst is the currently most bullish on PRQR (ProQR Therapeutics BV)?

Liisa Bayko with highest potential upside - $17.01

Which analyst is the currently most reserved on PRQR (ProQR Therapeutics BV)?

Eliana Merle with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?